{"metadata": {"organization_names": [], "person_names_verified": ["sam khichi"], "organization_names_verified": ["international healthcare partners llc", "catalent pharma solutions inc.", "catalent group", "bhp pts holdings l.l.c.", "pts holdings corp.", "catalent pharma solutions, inc."], "topics": [], "entities_rejected": [], "person_names": [], "agreement_id": "2d1522f8fbd7896c59dd32e72e7189d83da4d4c0a7bc6457cf274713e79b9d36", "vars": {}, "terms": ["**$**", "**BHP Equity**", "**Compliance with IRC Section 409A**", "**Counterparts**", "**Full Compliance**", "**Governing Law**", "**Litigation and Regulatory Cooperation**", "**Modifications/Severability**", "**No Additional Payments**", "**RELEASE AND WAIVER OF CLAIMS**", "**Restrictive Covenants**", "**Review of Agreement and Release**", "**Separation Date**", "**Severance Pay**", "**Subject: Separation Agreement and Release**", "**Successors**", "**Taxes**", "**The Consultant acknowledges that the Consultant has carefully read and understands this Release, that the Consultant has the right to consult an attorney with respect to its provisions and that this Release has been entered into voluntarily. The Consultant acknowledges that no representation, statement, promise, inducement, threat or suggestion has been made by any of the Released Parties to influence the Consultant to sign this Release except such statements as are expressly set forth herein or in the Separation Agreement.**", "*Purchased Equity*", "*Rest of Page Intentionally Left Blank*", "*Unvested Class C-1 Units*", "*Unvested Class C-2 Units and Class C-3 Units*", "*Vested Class B-1 Units and Class C-1 Units*", "\u2019 fees and costs actually incurred) or demands, in law or in equity, whether known or unknown, which may have existed or which may now exist from the beginning of time to the date of this Release, relating to any claims the Consultant may have arising from or relating to (i) the Consultant\u2019s Service (as defined in the Separation Agreement) or separation from Service with Holdings or any other member of the Catalent Group (as defined in the Separation Agreement), including, without limitation, the Consultant\u2019s service as a director of Holdings and Catalent Pharma Solutions, Inc. (\u201cCatalent\u201d", "\u201c2007 Subscription Agreement\u201d", "\u201c2008 Grant Agreement\u201d", "\u201c2010 Grant Agreement\u201d, together with the 2007 Subscription Agreement and the 2008 Grant Agreement, the \u201cUnit Agreements\u201d", "\u201c2010 Grant Agreement\u201d, together with the Subscription Agreement and the 2008 Grant Agreement, the \u201cUnit Agreements\u201d", "\u201cAdditional Vesting Period\u201d", "\u201cAgreement\u201d", "\u201cBHP\u201d", "\u201cCatalent\u201d", "\u201cConsultant\u201d", "\u201cConsulting Agreement\u201d", "\u201cHoldings\u201d", "\u201cLLC Agreement\u201d", "\u201cReleased Parties\u201d", "\u201cRelease\u201d", "\u201cRestrictive Covenants\u201d", "\u201cSection 409A\u201d", "\u201cSecurityholders Agreement\u201d", "\u201cSeparation Agreement\u201d", "\u201cSeparation Date\u201d", "\u201cSeverance Benefit\u201d", "\u201cSeverance Period\u201d", "\u201cSubscription Agreement\u201d", "\u201cYou\u201d"]}}